Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Masafumi, Masuda"'
Autor:
Hideki Yasui, Naoki Inui, Tomoyuki Fujisawa, Masato Karayama, Noriyuki Enomoto, Yutaro Nakamura, Shigeki Kuroishi, Hisano Ohba, Koshi Yokomura, Jun Sato, Masaki Sato, Naoki Koshimizu, Mikio Toyoshima, Takashi Yamada, Masafumi Masuda, Toshihiro Shirai, Takafumi Suda
Publikováno v:
Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, Vol 12 (2018)
Inhaled corticosteroids are widely used in the treatment of chronic obstructive pulmonary disease (COPD). However, their use has been questioned for appropriate dose and a possible increased risk of pneumonia. Here, we reviewed patients with COPD who
Externí odkaz:
https://doaj.org/article/42f07d03af3244768cadc4ec89999e5f
Autor:
Yoshikazu Inoue, Yasuhiko Yamano, Noriyoshi Ogawa, Shiro Imokawa, Yasuhiro Kondoh, Motoyasu Kato, Yoshio Taguchi, Masafumi Masuda, Noriyuki Enomoto, Hirofumi Chiba, Takafumi Suda, Kazutaka Mori, Hajime Takizawa, Yoshinori Tanino, Yasuhiko Nishioka, Mikio Toyoshima, Naoki Koshimizu, Yutaro Nakamura, Yusuke Kaida, Sakae Homma, Miho Kanai, Takehisa Sano, Hiroshi Mukae, Shinyu Izumi, Hiroyuki Matsuda, Naoki Hamada, Hironao Hozumi, Taisuke Akamatsu, Tomoyuki Fujisawa, Shigeo Muro, Takeshi Saraya, Koshi Yokomura, Naohiko Inase, Hiroshi Ishii, Shinobu Akagawa, Hironori Uruga
Publikováno v:
Thorax. 77:143-153
BackgroundSome patients with idiopathic interstitial pneumonia (IIP) show autoimmune features. Interstitial pneumonia with autoimmune features (IPAF) was recently proposed as a research concept in these patients. However, retrospective studies report
Autor:
Kazuko Ikegaya, Junichi Tokuhama, Seiji Harada, Masafumi Masuda, Atsuko Saito, Kana Fushimi, Ken Tsuchiya, Hiroki Ashizawa, Kazuma Saratani
Publikováno v:
Japanese Journal of Infection Prevention and Control. 36:149-156
Autor:
Taisuke Akamatsu, Toshihiro Shirai, Masato Kato, Dai Hashimoto, Hideki Yasui, Naoki Inui, Takafumi Suda, Koshi Yokomura, Hiroshi Hayakawa, Kyotaro Ide, Mikio Toyoshima, Shigeki Kuroishi, Kazumasa Yasuda, Hideki Suganuma, Takashi Yamada, Masafumi Masuda, Kingo Chida
Publikováno v:
Allergology International, Vol 61, Iss 2, Pp 323-329 (2012)
Background: Combination therapy with an inhaled corticosteroid (ICS) and a long-acting β2-agonist (LABA) in a single inhaler is the mainstay of asthma management and salmeterol/fluticasone combination (SFC) and fixed-dose formoterol/budesonide combi
Externí odkaz:
https://doaj.org/article/f41d6434bdca4ba6b63dd064c80b71d4
Autor:
Noriyuki Enomoto, Mikio Toyoshima, Naoki Koshimizu, Hiroyuki Matsuda, Takafumi Suda, Shiro Imokawa, Kazuhiro Asada, Tomoyuki Fujisawa, Yusuke Kaida, Yuzo Suzuki, Naoki Inui, Masafumi Masuda, Kazuki Furuhashi, Koushi Yokomura, Hiroshi Hayakawa, Hironao Hozumi, Takashi Yamada, Yutaro Nakamura, Hideki Kusagaya, Masato Karayama
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease. 14:1867-1877
Background Nivolumab, a programmed death 1 (PD-1) immune checkpoint inhibitor, has been shown to improve survival in non-small cell lung cancer (NSCLC). The possible involvement of PD-1 axis in the pathogenesis of inflammatory lung disease, such as c
Autor:
Kouji Takamori, Junichi Tokuhama, Hiroshi Shibata, Seiji Harada, Atsuko Saito, Kazuma Saratani, Ken Tsuchiya, Yuri Kasezawa, Masafumi Masuda, Kazuko Ikegaya, Kana Fushimi
Publikováno v:
Japanese Journal of Infection Prevention and Control. 33:136-142
Autor:
Kouji Takamori, Masafumi Masuda, Junichi Tokuhama, Kazuko Ikegaya, Hiroshi Shibata, Ken Tsuchiya, Kazuma Saratani, Kana Fushimi, Seiji Harada, Yuri Kasezawa, Atsuko Saito
Publikováno v:
Japanese Journal of Infection Prevention and Control. 33:56-61
Autor:
Kingo Chida, Shiro Imokawa, Mikio Toyoshima, Shigeki Kuroishi, Koshi Yokomura, Noriyuki Enomoto, Takashi Yamada, Masafumi Masuda, Toshihiro Shirai, Dai Hashimoto, Takafumi Suda, Hiroshi Hayakawa, Tomoyuki Fujisawa, Naoki Inui, Yutaro Nakamura, Kazutaka Mori
Publikováno v:
Respiratory Medicine. 119:1-6
Background The stepping down of asthma treatment can be considered when asthma symptoms have been well controlled with inhaled corticosteroids (ICSs)/long-acting β2 adrenergic agonists (LABAs). However, few data are available comparing the efficacy
Autor:
Yoshio Taguchi, M. Toyoshima, Hiroshi Ishii, Sakae Homma, Hiroki Takahashi, T. Suda, T. Akamatsu, S. Akagawa, H. Matsuda, Y. Yamano, Hiroshi Mukae, S. Imokawa, K. Yokomura, Yoshinori Tanino, Hajime Takizawa, Y. Inoue, Shigeo Muro, Y. Kaida, N. Koshimizu, H. Uruga, M. Kanai, Noriyuki Enomoto, Naohiko Inase, T. Sano, Motoyasu Kato, Masafumi Masuda, Yasuhiko Nishioka, S. Izumi, Naoki Hamada
Publikováno v:
B46. IDIOPATHIC INTERSTITIAL PNEUMONIA: NATURAL HISTORY.
Autor:
Shiro Imokawa, Yutaro Nakamura, Masato Karayama, Masaki Sato, Naoki Koshimizu, Noriyuki Enomoto, Koshi Yokomura, Masafumi Masuda, Takafumi Suda, Tomoyuki Fujisawa, Naoki Inui, Takashi Yamada, Mikio Toyoshima, Shigeki Kuroishi, Toshihiro Shirai
Publikováno v:
European Journal of Cancer. 58:30-37
Objectives Single agent maintenance therapy is widely accepted for advanced non-squamous non small cell lung cancer (NSCLC). However, there is no consensus on the initial and maintenance phase regimens, and the clinical benefit of adding bevacizumab